Gastroenterology
Volume 137, Issue 3 , Pages 873-884.e1 , September 2009

Decline in Male Sexual Desire, Function, and Satisfaction During and After Antiviral Therapy for Chronic Hepatitis C

  • Lorna M. Dove

      Affiliations

    • Division of Gastroenterology and Hepatology, Department of Internal Medicine, New York Presbyterian Medical Center, New York, New York
    • ,
  • Raymond C. Rosen

      Affiliations

    • New England Research Institutes, Watertown, Massachusetts
    • ,
  • Darmendra Ramcharran

      Affiliations

    • Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania
    • ,
  • Abdus S. Wahed

      Affiliations

    • Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania
    • ,
  • Steven H. Belle

      Affiliations

    • Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania
    • Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania
    • ,
  • Robert S. Brown

      Affiliations

    • Division of Gastroenterology and Hepatology, Department of Internal Medicine, New York Presbyterian Medical Center, New York, New York
    • ,
  • Jay H. Hoofnagle

      Affiliations

    • Liver Disease Research Branch, Division of Digestive Diseases and Nutrition, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland
    • Corresponding Author InformationReprint requests Address requests for reprints to: Jay H. Hoofnagle, MD, Liver Diseases Research Branch, Division of Digestive Diseases and Nutrition, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, 31 Center Drive, Room 9A27, Bethesda, Maryland 20892
    • ,
  • Virahep-C Study Group

Received 10 October 2008 ,Accepted 29 May 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Conflicts of interest The authors disclose no conflicts.

 Funding This study was funded as a cooperative agreement by the National Institute of Diabetes and Digestive and Kidney Diseases with cosupport from the National Center on Minority Health and Health Disparities and the Intramural Research Program of the National Cancer Institute with further support under a Cooperative Research and Development Agreement with Roche Laboratories, Inc. Supported by grants U01 DK60329, U01 DK60340, U01 DK60324, U01 DK60344, U01 DK60327, U01 DK60335, U01 DK60352, U01 DK60342, U01 DK60345, U01 DK60309, U01 DK60346, U01 DK60349, and U01 DK60341 and National Center for Research Resources General Clinical Research Centers Program grants M01 RR00645 (New York Presbyterian), M02 RR000079 (University of California, San Francisco), M01 RR16500 (University of Maryland), M01 RR000042 (University of Michigan), and M01 RR00046 (University of North Carolina). Peginterferon, ribavirin, HCV RNA detection assays, and funds for ancillary studies were provided by Roche Pharmaceutics through a Cooperative Research and Development Agreement between Roche and the National Institute of Diabetes and Digestive and Kidney Diseases. NCT Trial Number: NCT00038974.

PII: S0016-5085(09)00919-6

doi: 10.1053/j.gastro.2009.05.060

Gastroenterology
Volume 137, Issue 3 , Pages 873-884.e1 , September 2009

Article Tools

* Image Usage & Resolution